Vasculoprotection as a Convergent, Multi-Targeted Mechanism of Anti-Ad Therapeutics and Interventions

Journal of Alzheimer's Disease - Netherlands
doi 10.3233/jad-150098
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IOS Press

Related search

Targeted Therapeutics

Cell
BiochemistryGeneticsMolecular Biology
2011English

Rapalogs and mTOR Inhibitors as Anti-Aging Therapeutics

Journal of Clinical Investigation
Medicine
2013English

RNA-Targeted Therapeutics

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2019English

Anti-Caveolin-1 Antibodies as Anti-Prostate Cancer Therapeutics

Hybridoma
2012English

Anti-Transcription Factor RNA Aptamers as Potential Therapeutics

Nucleic Acid Therapeutics
BiochemistryMolecular MedicineDrug DiscoveryGeneticsMolecular Biology
2016English

Vitamin A-Aldehyde Adducts: AMD Risk and Targeted Therapeutics

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2016English

Novel Targeted Therapeutics for MEN2

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2018English

Integrin Targeted Delivery of Gene Therapeutics

Theranostics
MedicineToxicologyPharmaceuticsPharmacology
2011English

The Promise of Anti-ErbB3 Monoclonals as New Cancer Therapeutics

Oncotarget
Oncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy